Organization Overview
Historical Acquisition Tree
Alternative names
Key: Lantheus Medical Imaging (10) Acquired (1)
fludeoxyglucose f-18 (2014)
gadofosveset trisodium (ablavar) (2008)
gallium citrate ga 67 (1976 NDA)
perflutren protein-type a microspheres (Optison) (2001)
piflufolastat (PYLARIFY) (2021 NDA)
samarium-153 lexidronam (quadramet) (1997 NDA)
technetium-99m bicisate (1994 NDA)
technetium tc-99m sestamibi (Cardiolite) (1990 NDA)
thallous chloride ti 201 (1977 NDA)
ultra-technekow fm (1976)
xenon xe-133 (1974 NDA)
Key: Lantheus Medical Imaging (2) Acquired (2)
Key: Lantheus Medical Imaging (3) Acquired (1)
Key: Lantheus Medical Imaging (5) Acquired (12)
Key: Lantheus Medical Imaging (0) Acquired (9)
Carcinoma (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cardiovascular Diseases (Phase 4)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Coronary Restenosis (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 2)
Heart Diseases (Phase 4)
Heart Failure (Phase 2)
Infarction (Phase 4)
Ischemia (Phase 2)
Kidney Diseases (Phase 2)
Kidney Diseases, Cystic (Phase 2)
Kidney Neoplasms (Phase 2)
Mucocutaneous Lymph Node Syndrome (Phase 3)
Myocardial Infarction (Phase 4)
Myocardial Ischemia (Phase 4)
Pulmonary Heart Disease (Phase 4)
Renal Insufficiency, Chronic (Phase 2)
von Hippel-Lindau Disease (Phase 2)